Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wolters-kluwer-health/prednisolone-in-hbsag-positive-chronic-active-hepatitis-histologic-3G7qpISkZ0
References (23)
-
S. Huang (1975)
Immunohistochemical demonstration of hepatitis B core and surface antigens in paraffin sections.Laboratory investigation; a journal of technical methods and pathology, 33 1
-
J. Clemmesen, L. Elson, van Tg, McLean Ae, Roe Fj, R. Truhaut, D. Schmähl, Henri Tagnon (1976)
HUMAN CARCINOGENESISThe Lancet, 307
-
(1979)
The effect of immunosuppressive therapy on hepatitis B viral infection in patients with chronic hepatitis -
T. Shikata, T. Uzawa, N. Yoshiwara, T. Akatsuka, S. Yamazaki (1974)
Staining methods of Australia antigen in paraffin section--detection of cytoplasmic inclusion bodies.The Japanese journal of experimental medicine, 44 1
-
G. Cook, R. Mulligan, S. Sherlock (1971)
Controlled prospective trial of corticosteroid therapy in active chronic hepatitis.The Quarterly journal of medicine, 40 158
-
R. Soloway, W. Summerskill, A. Baggenstoss, Michael Geall, G. Gitnick, L. Elveback, L. Schoenfield (1972)
Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.Gastroenterology, 63 5
-
Huang Sn (1975)
Immunohistochemical demonstration of hepatitis B core and surface antigens in paraffin sections.Laboratory Investigation, 33
-
g) The amount of lipofuscin and iron pigment in hepatocytes, Kupffer cells, and connective tissue. The presence and degree of cholestasis (intracellular and extracellular) and steatosis -
W. Ellis, I. Murray-Lyon, J. Coleman, B. Evans, J. Fluker, J. Bull, P. Keeling, P. Simmons, J. Banatvala, J. Willcox, R. Thompson (1979)
LIVER DISEASE AMONG HOMOSEXUAL MALESThe Lancet, 313
-
b) Confluent necrosis occurring as bridging necrosis with passive or active septae formation and mul-tilobular necrosis -
S. Schalm, W. Summerskill, G. Gitnick, L. Elveback (1976)
Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.Gut, 17
-
(1977)
Nonparametric statistics for the behaviour sciences -
h) Proliferation of bile ducts and bile duct damage or -
(1969)
Effect of prednisone on the survival of patients with cirrhosis of the liver. A report from the Copenhagen Study Group for Liver Diseases.Lancet, 1 7586
-
A. Fauci (1978)
Mechanisms of the immunosuppressive and anti-inflammatory effects of glucocorticosteroids.Journal of immunopharmacology, 1 1
-
J. Jones, E. Engleman, J. Najarian (1965)
Systemic fat embolism after renal homotransplantation and treatment with corticosteroids.The New England journal of medicine, 273 27
-
(1968)
The natural history of active chronic hepatitis. I. Clinical features, course, diagnostic criteria, mortality and survival -
K. Lam, Ching‐lung Lai, R. Ng, C. Trépo, P. Wu (1981)
Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis.The New England journal of medicine, 304 7
-
P. Wu (1979)
Patterns of hepatitis B surface antigen. Localization in cells of hepatocellular carcinoma.Archives of pathology & laboratory medicine, 103 4
-
Burton Baker, Burton Baker, Dwight Ingle, Dwight Ingle, Choh Li, Choh Li, Herbert Evans, Herbert Evans (1948)
The effect on liver structure of treatment with adrenocorticotropin under varied dietary conditions.The American journal of anatomy, 82 1
-
(c) Features of viral hepatitis including balloon degeneration and acidophilic necrosis of hepatocytes, lobular disarray, and Kupffer cell proliferation -
I. Mackay (1972)
IMMUNOSUPPRESSIVE DRUGS AND CHRONIC HEPATITISMedical Journal of Australia, 1
-
E. Wright, L. Seeff, P. Berk, E. Jones, Paul Plötz (1977)
Treatment of chronic active hepatitis. An analysis of three controlled trials.Gastroenterology, 73 6
- Publisher
- Wolters Kluwer Health
- Copyright
- Copyright © 1982 American Association for the Study of Liver Diseases
- ISSN
- 0270-9139
- eISSN
- 1527-3350
- DOI
- 10.1002/hep.1840020605
- Publisher site
- See Article on Publisher Site
Abstract
To study the value of corticosteroids in HBsAg‐positive chronic active hepatitis, 18 pairs of liver histology comprising 36 liver biopsies from a prospective, randomized, controlled trial were evaluated. The median interval between the initial and follow‐up histology was 8 1/2 months in 8 patients given prednisolone and 8 1/4 months in 10 patients given placebo tablets. Following medication, there was significantly greater erosion of the limiting plate in the prenisolone group (p = 0.039) accompanied by a larger quantity of HBsAg (p = 0.045) and HBcAg (p = 0.006) in the liver. We conclude that prednisolone causes immunosuppression permitting enhanced viral multiplication and leads to increased erosion of the limiting plate. Our result also indicates that progression to cirrhosis is unhalted by prednisolone therapy. The histologic findings support clinico‐biochemical conclusion that the use of prednisolone is deleterious to patients with HBsAg‐positive chronic active hepatitis.
Journal
Hepatology – Wolters Kluwer Health
Published: Nov 1, 1982